TABLE I.
Demographic and Treatment Characteristics of Study Subjects
| Characteristics | n = 484 |
|---|---|
| Age at cancer diagnosis (years) | |
| Median | 3.90 |
| Range | 0–18 |
| Age at testing (years) | |
| Median | 12.26 |
| Range | 2.05–36.4 |
| Gender, n (%) | |
| Male | 234 (48.3%) |
| Female | 250 (51.7%) |
| Anthropometry (Mean ± SD) | |
| Height Z score | −0.78 ± 1.71 |
| BMI Z score | 0.27 ±1.34 |
| Race, n (%) | |
| White | 381 (78.7%) |
| Black | 59 (12.2%) |
| Hispanic | 3 (0.6%) |
| Asian | 41 (8.5%) |
| Puberty, n (%) | |
| Tanner 1–2 | 259 (53.5%) |
| Tanner 3–5 | 225 (46.5%) |
| Diagnosis, n (%) | |
| Brain tumor | 114 (23.5%) |
| Neuroblastoma | 101 (20.9%) |
| Leukemia | 85 (17.6%) |
| Non-malignant post SCT | 58 (11.9%) |
| Soft tissue Sarcoma | 44 (9.1%) |
| Bone tumors | 29 (6%) |
| Thyroid cancer | 28 (5.8%) |
| Miscellaneous | 15 (3.1%) |
| Hodgkins/non-Hodgkins Lymphoma | 10 (2.1%) |
| Treatment, n (%) | |
| Chemotherapy | 433 (89.4%) |
| Glucocorticoid | 73 (15.1%) |
| Radiation | 234 (48.3%) |
| Cranial Irradiation | 165 (34%) |
| Total body Irradiation | 69 (14%) |
| Endocrinopathy, n (%) | 225 (46.5%) |
BMI, body mass index; SCT, stem cell transplant.